Why the study?
Is intramyocardial hemorrhage associated with greater circulating inflammatory biomarker release compared to persistent microvascular obstruction in STEMI patients?
Population
STEMI patients
Comparison
Intramyocardial hemorrhage vs persistent MVO
Authors
Loading...
Positions IMH as a potential therapeutic target in STEMI; leaves open whether reducing it attenuates inflammation or improves outcomes.
Is intramyocardial hemorrhage associated with greater circulating inflammatory biomarker release compared to persistent microvascular obstruction in STEMI patients?
Intramyocardial hemorrhage is more strongly associated with inflammatory biomarker release than persistent MVO in STEMI patients, suggesting it as a potential therapeutic target.
Bochaton et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: